Hoth Therapeutics Financials
| HOTH Stock | USD 1.11 0.02 1.83% |
Hoth |
Understanding current and past Hoth Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hoth Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Hoth Therapeutics' assets may result in an increase in income on the income statement.
Hoth Therapeutics Stock Summary
Hoth Therapeutics competes with Avenue Therapeutics, Revelation Biosciences, Virax Biolabs, Zura Bio, and Phio Pharmaceuticals. Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York. Hoth Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US44148G2049 |
| CUSIP | 44148G105 44148G204 |
| Location | New York; U.S.A |
| Business Address | 590 Madison Avenue, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | hoththerapeutics.com |
| Phone | 646 756 2997 |
| Currency | USD - US Dollar |
Hoth Therapeutics Key Financial Ratios
| Return On Equity | -0.83 | ||||
| Return On Asset | -0.46 | ||||
| Target Price | 4.5 | ||||
| Beta | 0.85 |
Hoth Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hoth Therapeutics's current stock value. Our valuation model uses many indicators to compare Hoth Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hoth Therapeutics competition to find correlations between indicators driving Hoth Therapeutics's intrinsic value. More Info.Hoth Therapeutics is rated # 3 in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hoth Therapeutics' earnings, one of the primary drivers of an investment's value.Hoth Therapeutics Systematic Risk
Hoth Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Hoth Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Hoth Therapeutics correlated with the market. If Beta is less than 0 Hoth Therapeutics generally moves in the opposite direction as compared to the market. If Hoth Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Hoth Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Hoth Therapeutics is generally in the same direction as the market. If Beta > 1 Hoth Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
About Hoth Therapeutics Financials
What exactly are Hoth Therapeutics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Hoth Therapeutics' income statement, its balance sheet, and the statement of cash flows. Potential Hoth Therapeutics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Hoth Therapeutics investors may use each financial statement separately, they are all related. The changes in Hoth Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hoth Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Hoth Therapeutics March 15, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Hoth Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hoth Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hoth Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Hoth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hoth Therapeutics's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.13 | |||
| Information Ratio | 0.0876 | |||
| Maximum Drawdown | 196.04 | |||
| Value At Risk | (8.06) | |||
| Potential Upside | 5.88 |
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |